newsfilter
← Latest News
GlobeNewswire·

Outlook Therapeutics to Present at the Eyecelerator@AAO 2021 Conference Retina Showcases

ISELIN, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today an